(SCHA) Schwab U.S. Small-Cap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085246077

SCHA: Small-Cap, Stocks, Dow Jones Index, ETF

The Schwab U.S. Small-Cap ETF (SCHA) is designed to track the performance of the Dow Jones U.S. Small-Cap Total Stock Market Index, which comprises approximately 1,750 small-cap stocks ranked 751-2500 by market capitalization. This index is a subset of the broader Dow Jones U.S. Total Stock Market Index and is weighted by float-adjusted market capitalization, meaning that the stocks with the largest market capitalization have a greater influence on the indexs performance.

The funds investment strategy involves holding at least 90% of its net assets in the stocks that make up the index, providing investors with broad exposure to the small-cap segment of the U.S. equity market. With an AUM of $16.8 billion, SCHA is one of the larger small-cap ETFs available, offering liquidity and diversification benefits to investors.

From a technical analysis perspective, SCHAs price action suggests a potential bullish trend. The ETF is currently trading above its 20-day simple moving average (SMA20) of $24.32, indicating a short-term uptrend. Additionally, the 50-day simple moving average (SMA50) of $23.24 is below the current price, further supporting the bullish case. However, the 200-day simple moving average (SMA200) of $25.14 is above the current price, indicating that the long-term trend is still uncertain.

Using a combination of technical and fundamental analysis, we can forecast that SCHA may continue to experience a short-term uptrend, driven by the ongoing recovery in the U.S. small-cap market. With the ETFs low average true range (ATR) of 0.41, or 1.66%, indicating relatively stable price action, investors may be able to capitalize on the potential upside while minimizing downside risk. As the U.S. economy continues to grow, small-cap stocks are likely to benefit, driving SCHAs performance higher. In the next 6-12 months, we forecast that SCHA may reach $27.50, representing a 12% increase from current levels.

Additional Sources for SCHA ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

SCHA ETF Overview

Market Cap in USD 17,054m
Category Small Blend
TER 0.04%
IPO / Inception 2009-11-03

SCHA ETF Ratings

Growth Rating 32.7
Fundamental -
Dividend Rating 54.3
Rel. Strength -3.47
Analysts -
Fair Price Momentum 22.85 USD
Fair Price DCF -

SCHA Dividends

Dividend Yield 12m 1.58%
Yield on Cost 5y 2.60%
Annual Growth 5y 10.85%
Payout Consistency 90.1%
Payout Ratio %

SCHA Growth Ratios

Growth Correlation 3m 67.2%
Growth Correlation 12m -9.9%
Growth Correlation 5y 44.7%
CAGR 5y 10.38%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 0.23
Alpha -4.22
Beta 1.063
Volatility 18.33%
Current Volume 3498.7k
Average Volume 20d 2515.7k
What is the price of SCHA shares?
As of June 19, 2025, the stock is trading at USD 24.64 with a total of 3,498,682 shares traded.
Over the past week, the price has changed by -1.44%, over one month by -0.12%, over three months by +3.59% and over the past year by +6.48%.
Is Schwab U.S. Small-Cap a good stock to buy?
Neither. Based on ValueRay´s Analyses, Schwab U.S. Small-Cap is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.68 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SCHA is around 22.85 USD . This means that SCHA is currently overvalued and has a potential downside of -7.26%.
Is SCHA a buy, sell or hold?
Schwab U.S. Small-Cap has no consensus analysts rating.
What are the forecasts for SCHA share price target?
According to our own proprietary Forecast Model, SCHA Schwab U.S. Small-Cap will be worth about 26 in June 2026. The stock is currently trading at 24.64. This means that the stock has a potential upside of +5.32%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26 5.3%